Pharmahungary Group

More than a CRO, your creative R&D team™ Mission of Pharmahungary - providing wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) and metabolic diseases (diabetes, dyslipidemia, atherosclerosis, obesity, uremia, etc) with strong scientific support - clinical R&D services focusing on special clinical studies including medical device that need sensitive patient population and thereby strong regulatory & scientific support - to manage internal R&D projects to develop new technologies for outlicensing in the fileds of diagnosis and therapy of cardiovascular and metabolic diseases Why Pharmahungary- Full service: creative, cost-effective, flexible, high quality - Internationally trained management & staff (MDs, PhDs, clinical pharmacologists, PharmDs, chemists, biologists, medical engineers, MBA quality managers)- Complex platforms of cardiovascular and metabolic disease models- Custom design models with co-morbidities, including large animals - Strong biochemical and molecular biological background for complex proof-of-concept studies - Scientific support based on international scientific excellence (publications over 380, impact factors over 1 400, citations over 26 Strict confidentiality, IP rights under regulations of the European Union For more information please visit: